POINT Biopharma Global Inc. Profile Avatar - Palmy Investing

POINT Biopharma Global Inc.

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand …

Biotechnology
US, Indianapolis [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of PNT's Analysis
CIK: 1811764 CUSIP: 730541109 ISIN: US7305411099 LEI: - UEI: -
Secondary Listings
PNT has no secondary listings inside our databases.